Methimazole and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methimazole (methimazole) and Keppra (levetiracetam). Common drug interactions include cerebrovascular accident among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Methimazole and Keppra. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Methimazole?

Methimazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 8,016 Methimazole users. Check the latest studies of Methimazole.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

On Jul, 06, 2026

25 people who take Methimazole and Keppra together, and have interactions are studied.

Methimazole and Keppra drug interactions.

What are the common drug interactions of Methimazole and Keppra, by gender? *:

female:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Vision blurred
Hemiplegia (paralysis of one side of the body)
Drug ineffective
Headache (pain in head)
Pain
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Cataract (clouding of the lens inside the eye)
Complex partial seizures (epileptic seizure)
Ear discomfort

male:

Nausea (feeling of having an urge to vomit)
Alopecia (absence of hair from areas of the body)
Death
Diarrhoea
Diarrhoea haemorrhagic (bloody diarrhoea)
Dry skin
Eructation (release of gas from the digestive tract)
Feeding disorder (when children refuse to eat certain food groups)
Flatulence (flatus expelled through the anus)
Granulocytopenia (lack of granulocyte)

What are the common drug interactions of Methimazole and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Cardiac failure congestive
Haematocrit decreased
Haemoglobin decreased
Headache (pain in head)
Leukopenia (less number of white blood cells in blood)
Nephrolithiasis (calculi in the kidneys)
Neutropenia (an abnormally low number of neutrophils)
Oropharyngeal pain
Platelet count decreased
Pneumonia

30-39:

Drug ineffective

40-49:

Complex partial seizures (epileptic seizure)
Drug ineffective
Ear discomfort
Eye pain
Fatigue (feeling of tiredness)
Headache (pain in head)
Hyperacusis (disorder in loudness perception)
Hypertension (high blood pressure)
Inappropriate affect
Pain

50-59:

n/a

60+:

Chronic kidney disease
Death
Oedema (fluid collection in tissue)
Renal failure (kidney dysfunction)
Urinary tract infection

What are the existing conditions these people have? *

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 28.00%
Pain: 4 people, 16.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 12.00%
Neuralgia (pain in one or more nerves): 3 people, 12.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 12.00%
Insomnia (sleeplessness): 2 people, 8.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%
Blood Pressure Abnormal: 2 people, 8.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Methimazole and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously